Table 1 Clinicopathological parameters of patients in the upfront surgery group according to the presence of LNM.

From: Comparative microRNA signatures based on liquid biopsy to identify lymph node metastasis in T1 colorectal cancer patients undergoing upfront surgery or endoscopic resection

Variable

LNM positive (n = 14)

LNM negative (n = 83)

p-value

Demographic data

 Age, years

62 (49–76)

66 (37–94)

0.64

 Sex, male

7 (50%)

43 (52%)

0.90

Tumor location

  

0.35

 Cecum

3 (21%)

13 (16%)

 

 Ascending colon

1 (7%)

20 (24%)

 

 Transverse colon

0 (0%)

5 (6%)

 

 Descending colon

0 (0%)

6 (7%)

 

 Sigmoid colon

5 (36%)

13 (16%)

 

 Rectum

5 (36%)

26 (31%)

 

Tumor size, mm

21 (8–35)

19 (5–53)

1.0

Tumor type

  

0.71

 Polypoid

6 (43%)

41 (49%)

 

 Flat

1 (7%)

11 (13%)

 

 Depressed

7 (50%)

31 (37%)

 

Tumor histology

  

0.41

 Well

5 (36%)

45 (54%)

 

 Moderate

5 (36%)

23 (28%)

 

 Poor

4 (29%)

15 (18%)

 

Tumor depth (µm)

  

0.11

 <1000

0 (0%)

5 (6%)

 

 1000–1999

0 (0%)

58 (70%)

 

 ≥2000

13 (93%)

17 (20%)

 

 Unavailable

1 (7%)

3 (4%)

 

Lymphatic invasion

  

1.0

 Positive

1 (7%)

10 (12%)

 

 Negative

13 (93%)

73 (88%)

 

Vascular invasion

  

0.15

 Positive

9 (64%)

36 (43%)

 

 Negative

5 (36%)

47 (57%)

 

Tumor budding

  

0.13

 Grade 1

8 (57%)

63 (76%)

 

 Grade 2

2 (14%)

8 (10%)

 

 Grade 3

2 (14%)

2 (2%)

 

 Unavailable

2 (14%)

10 (12%)

 
  1. Values are presented as the number of patients (%) or the median (range).